Natco Pharma: Announcement under Regulation 30 (LODR)-Change in Management

1. Superannuation of Mr. S V V N Appa Rao Chief Financial Officer w.e.f. closure of business hours on 12th February 20262. Appointment of Mr. Amit Parekh as Chief Financial Officer of the Company w.e.f. 13th February 2026.3. Appointment of Mr. K Srinivasa Rao as Executive Vice President- Pharma Division w.e.f. 12th February 2026